RenovoRx(RNXT)
$1.22+0.04 (+3.39%)
RNXT
RenovoRx financials statements
$1.22
At close:+0.04 (+3.39%)
Want to see RNXT full AI Analyst Report?
RenovoRx (RNXT) Income Statement
208 Followers
RenovoRx Income Statement
Last quarter (Q3 2026), RenovoRx's total revenue was $1.07M, an increase of 300.75% from the same quarter last year. In Q3, RenovoRx's net income was $-3.65M. See RenovoRx’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 1.12M | $ 43.00K | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 796.00K | $ 43.00K | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 13.31M | $ 11.01M | $ 11.40M | $ 9.95M | $ 5.67M | |
| Depreciation and Amortization | $ 2.00K | $ 0.00 | $ 6.00K | $ 6.00K | $ 9.00K |
| $ -11.17M | $ -8.81M | $ -10.12M | $ -9.83M | $ -5.48M | |
| $ -12.51M | $ -10.97M | $ -11.40M | $ -9.95M | $ -5.67M | |
| $ 1.34M | $ 2.16M | $ 1.16M | $ 61.00K | $ -653.00K | |
| $ -11.17M | $ -8.81M | $ -10.23M | $ -9.89M | $ -6.32M | |
| $ -11.17M | $ -8.81M | $ -10.23M | $ -9.89M | $ -6.32M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.32 | $ -0.37 | $ -0.50 | $ -0.54 | $ -0.40 |
| Diluted EPS | $ -0.32 | $ -0.37 | $ -0.50 | $ -0.54 | $ -0.40 |
| Weighted Average Shares Outstanding | 35.33M | 23.61M | 20.58M | 18.10M | 17.87M |
| Weighted Average Shares Outstanding (Diluted) | 35.33M | 23.61M | 20.58M | 18.10M | 17.87M |
Currency in USD
